Into the Suprachoroidal Space: The Next Frontier in Treatment of Posterior Segment Eye Disease

Into the Suprachoroidal Space The Next Frontier in Treatment of Posterior Segment Eye Disease
Details
  • Overview

    The suprachoroidal space is a prospective pathway for novel drug delivery systems to treat posterior segment eye diseases, including uveitic macular edema. Join Drs. Srivastava, Sharma, and Yeh to learn about administration techniques and clinical trial results.

    This activity is supported by an unrestricted medical educational grant from Bausch + Lomb.

     

  • Learning Objectives

    Upon completion of this activity, the participant should be able to:

    • Develop treatment plans for uveitic macular edema that incorporate new agents when appropriate based on recent clinical data and FDA approvals.
    • Describe proper administration techniques of suprachoroidal injections, solutions to common challenges, and best practices in patient education and informed consent.
    • Assess clinical trial results examining the suprachoroidal space as a potential pathway for future treatments in eye diseases of the posterior segment.
    • Accreditation

      Provided by Evolve Medical Education 

      Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
      Evolve designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

      Successful completion of this CME activity, which includes participation in the evaluation component, earns credit toward the Lifelong Learning requirement[s] for the American Board of Ophthalmology’s Continuing Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting credit.

       

    • Participation Method

      In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.

    • Faculty and Disclosures

      Sunil K. Srivastava, MD

      Sunil K. Srivastava, MD

      Surgical Retina Fellowship Director
      Cleveland Clinic Cole Eye Institute
      Cleveland, OH


      Sumit Sharma, MD

      Sumit Sharma, MD

      Assistant Professor, Ophthalmology
      Cleveland Clinic
      Lerner College of Medicine
      Case Western Reserve University Staff

      in Vitreoretinal Surgery and Uveitis
      Cleveland Clinic Cole Eye Institute
      Cleveland, OH


      Steven Yeh, MD

      Steven Yeh, MD

      Professor and Stanley Truhlsen Jr. 
      Chair in Ophthalmology
      Truhlsen Eye Institute
      University of Nebraska Medical Center
      Omaha, NE
      Adjunct Professor
      Emory University School of Medicine
      Atlanta, GA


      DISCLOSURE POLICY
      It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.

      The following faculty/staff members have the following financial relationships with ineligible companies.

      Sunil K. Srivastava, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: AbbVie, Adverum Biotechnologies, Allergan, Bausch + Lomb, Carl Zeiss Meditec, EyePoint Pharmaceuticals, Eyevensys, jCyte, Novartis, and Regeneron Pharmaceuticals. Grant/Research Support: Bausch + Lomb, EyePoint Pharmaceuticals, Eyevensys, jCyte, Novartis, and Regeneron Pharmaceuticals.

      Sumit Sharma, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: AbbVie, Bausch + Lomb, Clearside, EyePoint Pharmaceuticals, Genentech, Regeneron, and RegenxBio. Grant/Research Support: Genentech, Gilead Sciences, Ionis, and Santen.

      Steven Yeh, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Adverum Biotechnologies, Alcon, Bausch + Lomb, EyePoint Pharmaceuticals, and RegenxBio. Grant/Research Support: NIH/NEI and Truhlsen Family Foundation.

      The Evolve staff and planners have no financial relationships with ineligible companies.
      Nisha Mukherjee, MD, peer reviewer, has no financial relationships with ineligible companies.

       

    • Disclaimer

      OFF-LABEL STATEMENT
      This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

      DISCLAIMER
      The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Bausch + Lomb.

      This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

       

      This program is not affiliated with the official CME program of AAO 2022.

       

    • System Requirements

      • Supported Browsers (2 most recent versions):
        • Google Chrome for Windows, Mac OS, iOS, and Android
        • Apple Safari for Mac OS and iOS
        • Mozilla Firefox for Windows, Mac OS, iOS, and Android
        • Microsoft Edge for Windows
      • Recommended Internet Speed: 5Mbps+

    • Publication Dates

      Expiration Date:

    1.50 credits
    Completing the pre-test is required to access this content.
    Completing the pre-survey is required to view this content.

    Ready to Claim Your Credits?

    You have attempts to pass this post-test. Take your time and review carefully before submitting.

    Good luck!

    Register

    We're glad to see you're enjoying Evolve Medical Education…
    but how about a more personalized experience?

    Register for free